Afthought

Russian Roulette Pays Off for Antigenics

I guess Big Pharma has not managed to bribe the right people in the Russian drug approval process. Their problem is that US methods of persuasion do not transfer to the Russian economy. Maybe DNDN, etc. will wise up and take their research someplace other than the US so that their products can be delivered to people who so desparately need them in order to survive.